GENE ONLINE|News &
Opinion
Blog

Type 2 Diabetes
China APACChinaInsulinDiabetesStem Cell Therapy
Breakthrough Cell Transplant Frees Chinese Patient from Insulin Dependency
2024-06-05
Manufacturing Type 2 Diabetes
AstraZeneca Invests $26.5 Million in New Production Line for Diabetes Drug in China
2024-01-19
R&D Semaglutide
Semaglutide-Based Medications, Ozempic and Wegovy, Show Lower Suicidal Ideation Risk
2024-01-17
Special biotech
GeneOnline’s Pick: Top 10 Global Biotech News Stories in 2023
2023-12-27
Innovation Type 2 Diabeteshydrogel
Novel Hydrogel Delivery System Could Reduce Daily Diabetes Injections to Three Times a Year
2023-12-04
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
Innovation InsulinBeta Cell
U.S.-German Joint Discovery May Spark Breakthrough in Diabetes Research
2023-03-29
Trending Type 2 Diabetes
CDC Says Childhood Diabetes Could Increase Nearly 700% By 2060
2023-01-03
Special FDA Approval
GeneOnline’s Pick: Top 10 New FDA-approved Drugs in 2022
2022-12-30
R&D Dementia
Oral Diabetes Drug May Protect Elderly From Dementia
2022-12-16
Trials & Approvals Novo Nordisk
Novo Nordisk’s Once-Weekly Insulin Snags Another Victory
2022-09-22
Trials & Approvals Diabetes
Novo Nordisk’s Type 2 Diabetes Drug Gets Greenlight in Korea
2022-05-04
Technology Diabetes
Novel RAGE Antagonist Stirs Hopes for Countering Diabetic Complications
2021-12-07
Trials & Approvals Type 2 Diabetes
FDA Greenlights AstraZeneca’s Blockbuster Drug for Chronic Kidney Disease
2021-05-02
Trials & Approvals Heart Failure
Forxiga Gains Approval in China for Multiple Cardio-Related Diseases
2021-02-07
1 2
LATEST
Sanofi and Regeneron’s Dupixent Approved as First-in-World Treatment For Uncontrolled COPD
2024-07-04
Advancements in Alzheimer’s Disease Drug Innovation and Funding Programs in 2024
2024-07-04
FDA Greenlights Eli Lilly’s Groundbreaking Alzheimer’s Drug Kisunla for Early Symptomatic Treatment
2024-07-04
BIO Asia–Taiwan 2024 Set to Showcase Global Biotech Industry Talent on July 24th
2024-07-03
Novo Nordisk’s CLARION-CKD Trial Shut Down After Unsuccessful Results Causing Impairment Loss
2024-07-03
Tanvex BioPharma Secures Asia’s First FDA Approval for Filgrastim Biosimilar, Seizing a $403 Million Market
2024-07-03
Ginkgo Job Cuts Expected to Affect at Least 35% of Workforce, Eliminating Over 400 Jobs
2024-07-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top